Skip Navigation
Menu
Editorials |1 February 1997

Management of Atrial Fibrillation: Simplicity Surrounded by Controversy

Eric N. Prystowsky, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright ©2004 by the American College of Physicians
2004
  • Northside Cardiology, Indianapolis, IN 46260 Requests for Reprints: Eric N. Prystowsky, MD, Northside Cardiology, 8333 Naab Road, Indianapolis, IN 46260.
×
FULL TEXT
Atrial fibrillation appears to be the most common sustained tachyarrhythmia encountered in clinical practice; it increases in frequency with age and the presence of structural heart disease [1]. It has neither the glamour of the Wolff-Parkinson-White syndrome nor the drama of sudden cardiac death, and it appears to be simple to treat. Yet no other arrhythmia is surrounded by so much controversy with regard to management strategies.
Three major tenets govern therapy for atrial fibrillation: maintenance of sinus rhythm, control of ventricular rate, and prevention of thromboembolism. The relative benefit of sinus rhythm over a controlled fibrillating rate is controversial. The advantages of sinus rhythm include elimination of arrhythmic symptoms; improvement in the hemodynamic profile; possible prevention of established (cardioversion-resistant) atrial fibrillation; and a likely, although unproven, decrease in the risk for cardiac thromboemboli [1-3]. Because antiarrhythmic drugs are the method most commonly used to maintain sinus rhythm, the major associated risks are pharmacologic side effects, including potentially lethal ventricular arrhythmias [4]. Judicious selection of antiarrhythmic drugs, done on the basis of the causes of atrial fibrillation and the type of cardiac pathology, and initiation of therapy in the hospital in selected patients should decrease the incidence of and the morbidity and mortality associated with such arrhythmias [5].
Regardless of the potential benefits of sinus rhythm, many physicians think that the risks of drug therapy and the difficulty of maintaining sinus rhythm are arguments for the alternative approach to the treatment of atrial fibrillation: ventricular rate...
FULL TEXT
PDF
Not Available
Citations
Citation

Prystowsky EN. Management of Atrial Fibrillation: Simplicity Surrounded by Controversy. Ann Intern Med. 1997;126:244–246. doi: 10.7326/0003-4819-126-3-199702010-00012

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1997;126(3):244-246.

DOI: 10.7326/0003-4819-126-3-199702010-00012

16 Citations

Related Articles
Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion
Annals of Internal Medicine; 157 (6): JC3-9
Risk for Clinical Thromboembolism Associated with Conversion to Sinus Rhythm in Patients with Atrial Fibrillation Lasting Less Than 48 Hours
Annals of Internal Medicine; 126 (8): 615-620
Atrial Fibrillation: Restoration and Maintenance of Sinus Rhythm and Indications for Anticoagulation Therapy
Annals of Internal Medicine; 125 (4): 311-323
Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease: A Randomized, Controlled Trial
Annals of Internal Medicine; 126 (8): 621-625
View MoreView Less

Journal Club
Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion
Annals of Internal Medicine; 157 (6): JC3-9
Review: In noncardiac surgery, amiodarone, β-blocker, or statin prophylaxis reduces postoperative AF
Annals of Internal Medicine; 169 (2): JC7
Review: After PCI in AF, OAC plus single vs dual antiplatelets reduces major bleeding; no difference for MACE
Annals of Internal Medicine; 169 (2): JC8
In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF
Annals of Internal Medicine; 168 (10): JC55
View MoreView Less

Related Point of Care
Atrial Fibrillation
Annals of Internal Medicine; 166 (5): ITC33-ITC48
Atrial Fibrillation
Annals of Internal Medicine; 153 (11): ITC6-1
Atrial Fibrillation
Annals of Internal Medicine; 149 (9): ITC5-1
View MoreView Less

Related Topics
Cardiology
Rhythm Disorders and Devices

Cardiology, Rhythm Disorders and Devices.

PubMed Articles
Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.
Cardiology 2019.
Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation - Relationships and Predictors for Procedure Success after Catheter Ablation.
Arq Bras Cardiol 2019;112(5):509-510.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×